OBJECTIVE: Description of the various autoantibodies that can be detected in patients with
systemic lupus erythematosus (SLE). METHODS: A literature review, using the terms …

Antibodies to prothrombin are detected by directly coating prothrombin on irradiated ELISA
plates (aPT) or by using the phosphatidylserine/prothrombin complex as antigen (aPS/PT) …

The association of antiphospholipid antibodies with thrombosis and obstetric events defines
the antiphospholipid syndrome. A recent systematic review of the literature showed lupus …

Objective Non-criteria antiphospholipid antibodies (aPLs) increase the diagnostic value for
antiphospholipid syndrome (APS) and contribute to better recognition of seronegative APS …

The objective of this study was to characterize risk factors for thrombotic events in lupus
patients. A total of 272 lupus patients were followed up for five years during which the …

Among the diagnostic assays for anti-phospholipid syndrome (APS), lupus anticoagulant
(LA) is the strongest predictor of thrombosis; however, it presents several limitations as …

Objective: To evaluate the role of anti‐prothrombin (anti‐PT) antibodies in predicting
thrombosis in patients with systemic lupus erythematosus (SLE). Methods: An inception …

We retrospectively analysed the data of 1519 antiphospholipid antibody (APLA) positive
patients between 1986 and 1999. Among them 637 were considered to have …

Despite the strong association between antiphospholipid antibodies (aPL) and thrombosis,
the pathogenic role of aPL in the development of thrombosis has not been fully elucidated …

Background: Annexin A5 is thought to have a role in the pathophysiology of the
antiphospholipid syndrome (APS)—a syndrome characterised by recurrent thrombosis and …